Tencent-backed telemedicine service Miaoshou Doctor pulled in $84.5m that will support the strengthening of its health insurance provision.
Miaoshou Doctor, the China-based telemedicine platform developer backed by internet group Tencent, secured RMB200m ($84.5m) in series D1 funding today.
The round was revealed by venture capital firm Qiming Partners through an announcement on its WeChat account. Qiming invested alongside Ince Capital, Sequoia Capital China, Citic Securities and Index Capital.
Formally known as Beijing Yuanxin Technology, Miaoshou Doctor operates an online platform that enables patients to schedule remote meetings with doctors through phone or video calls in addition to getting…